|
FIN 2013
COI 2.34 %
*
Breed relevant health information:
Canine Multifocal Retinopathy 3 (CMR3)
N/N (clear)
-
8/4/2020
Degenerative myelopathy (DM)
N/N (clear)
-
8/4/2020
Glycogen storage disease type II (Pompe disease) (GSDII)
N/N (clear)
-
8/4/2020
Hips
Fair / B1 / 4-6 / B / 11-18
Progressive retinal atrophy (prcd-PRA)
N/N (clear)
-
8/4/2020
|
FIN 2012
COI 2.70 %
*
Breed relevant health information:
Hips
Fair / B1 / 4-6 / B / 11-18
-
15/3/2013
|
FIN 2008
COI 0.87 %
*
Breed relevant health information:
Hips
Good / A2 / 1-3 / A / 5-10 (no >6/hip)
-
17/8/2010
Year of death:
2021
|
FIN 2009
COI 2.55 %
*
Breed relevant health information:
Hips
Mild / C1 / 9-12 / C / 26-35
-
31/8/2010
|
|||
|
|
||
|
|||
|
FIN 2005
COI 2.97 %
*
Breed relevant health information:
Glycogen storage disease type II (Pompe disease) (GSDII)
N/N (clear)
Hips
Excellent / A1 / 0 / A / 0-4 (no >3/hip)
Progressive retinal atrophy (prcd-PRA)
N/N (clear)
|
FIN 2001
COI 2.57 %
*
Breed relevant health information:
Hips
Excellent / A1 / 0 / A / 0-4 (no >3/hip)
|
|
FIN 1999
COI 4.47 %
*
Breed relevant health information:
Hips
Borderline / B2 / 7-8 / B / 19-25
-
11/10/2000
|
|||
|
|
||
FIN 2006
COI 4.67 %
*
Breed relevant health information:
Hips
Excellent / A1 / 0 / A / 0-4 (no >3/hip)
|